Dr. Christopher John Rizzi, MD

Dr. Rizzi practices at Rochester General Hospital in Rochester, New York, part of Rochester Regional Health.

Dr. Rizzi's NPI, 1427390160, was assigned on March 20, 2013. Dr. Rizzi holds New York license 310314.

Dr. Rizzi's primary practice is Rochester General Hospital, at 1425 Portland Avenue, Rochester, NY 14621 in Monroe County. The practice phone is (585) 922-4000.

Dr. Rizzi's primary practice is Rochester General Hospital in Rochester, New York, part of Rochester Regional Health. Dr. Rizzi is also affiliated with Unity Hospital. The medical group on file is Rochester General Hospital. Dmand AI also links Dr. Rizzi to 4 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rizzi practices, 3 sites in all. Vendor and product names are available with a free account.

Plastic surgery within the head and neck is Dr. Rizzi's primary specialty in the NPI Registry, under taxonomy code 207YX0007X. Dr. Rizzi is licensed in New York.

CMS data shows 192 Medicare services from Dr. Rizzi across 7 procedure codes in 2024, for 107 Medicare patients. Medicare paid $16,309 for them. Every service was in an office.

CMS counts 107 Medicare patients who saw Dr. Rizzi in 2024. The largest group is 65 to 74, with 39 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 36% are also on Medicaid. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rizzi's median patient age at 62, with 58% women.

In 2024, Dr. Rizzi wrote 401 Medicare Part D claims for 195 patients. 100% of them were for generic drugs. CMS names the drug for 304 of them, across 9 drugs with 11 or more claims each, at $4,936 in total drug cost. In 2023, CMS named 370 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Rizzi for performance year 2024, reported through an alternative payment model (APM). Dr. Rizzi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rizzi as offering telehealth. CMS counts 13 procedures of melanoma (skin cancer) excision by Dr. Rizzi, more than 67% of the clinicians it reports for that procedure.

Dmand AI links 6 papers to Dr. Rizzi, published from 2013 to 2017. 2017 was the busiest year, with 2. Dr. Rizzi's most frequent co-authors are Jewel D. Greywoode, MD, Kavita Vakharia, MD and Julian Amin.

CMS Open Payments shows 40 general payments to Dr. Rizzi from 13 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 67% of the total. Osteomed LLC paid the most, $954.